Literature DB >> 9763144

Parathyroid hormone induces interleukin-6 heterogeneous nuclear and messenger RNA expression in murine calvarial organ cultures.

Y F Huang1, J R Harrison, J A Lorenzo, B E Kream.   

Abstract

The cytokine, interleukin-6 (IL-6), is produced by osteoblasts and may in part mediate parathyroid hormone (PTH)-stimulated bone resorption. The goals of the present study were: (1) to examine PTH induction of IL-6 expression in 7-day-old mouse calvarial organ cultures; (2) to assess the role of intracellular signaling pathways in this model; and (3) to determine whether PTH regulates IL-6 expression by a transcriptional mechanism. Northern blot analysis of calvarial RNA showed that PTH(1-34) at 0.1-100 nmol/L induced IL-6 mRNA at 0.5 h with a peak at 2 h. Forskolin at 10 micromol/L and 8-bromocyclic-AMP at 3 mmol/L also induced IL-6 mRNA with a peak at 2 h. Phorbol myristate acetate induced IL-6 expression, whereas ionomycin and PTH(3-34) amide, an N-terminal-truncated PTH analog that has reduced ability to activate the cAMP-PKA pathway, were much less effective. PMA pretreatment of calvariae greatly blocked IL-6 mRNA induction by a subsequent dose of PMA and decreased induction by PTH and forskolin to a much lesser extent. A reverse-transcriptase polymerase chain reaction (RT-PCR) assay was used to measure IL-6 heterogeneous nuclear RNA (hnRNA) and mRNA. A 5' primer spanning exons 1 and 2 and a 3' primer complementary to exon 5 of the murine IL-6 gene were used to detect IL-6 mRNA as a 638 bp product. A 5' primer corresponding to intron 4 of the murine IL-6 gene and the 3' primer were used to detect IL-6 hnRNA as a 370 bp product. RT-PCR of total calvarial RNA showed that the induction of IL-6 hnRNA by PTH and other agonists was similar to their induction of IL-6 mRNA. These data support the conclusion that PTH transcriptionally induces IL-6 gene expression in murine calvarial organ cultures mainly through the cAMP-PKA signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9763144     DOI: 10.1016/s8756-3282(98)00115-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  6 in total

1.  Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.

Authors:  Qiang Fu; Stavros C Manolagas; Charles A O'Brien
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth.

Authors:  Serk In Park; Changki Lee; W David Sadler; Amy J Koh; Jacqueline Jones; Jung Won Seo; Fabiana N Soki; Sun Wook Cho; Stephanie D Daignault; Laurie K McCauley
Journal:  Cancer Res       Date:  2013-09-26       Impact factor: 12.701

3.  Hyperlipidemia impairs osteoanabolic effects of PTH.

Authors:  Michael S Huang; Jinxiu Lu; Yevgeniy Ivanov; Andrew P Sage; Wendy Tseng; Linda L Demer; Yin Tintut
Journal:  J Bone Miner Res       Date:  2008-10       Impact factor: 6.741

4.  Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective.

Authors:  André Barkhordarian; Reem Ajaj; Manisha H Ramchandani; Gary Demerjian; Riana Cayabyab; Sohrab Danaie; Nora Ghodousi; Natasha Iyer; Nicole Mahanian; Linda Phi; Amy Giroux; Ercolano Manfrini; Negoita Neagos; Muniza Siddiqui; Olivia S Cajulis; Xenia M C Brant; Paul Shapshak; Francesco Chiappelli
Journal:  Patholog Res Int       Date:  2011-05-21

5.  Models of ex vivo explant cultures: applications in bone research.

Authors:  Silvia Marino; Katherine Ann Staines; Genevieve Brown; Rachel Anne Howard-Jones; Magdalena Adamczyk
Journal:  Bonekey Rep       Date:  2016-06-29

6.  Immunoregulation of bone remodelling.

Authors:  Ajai Singh; Abbass A Mehdi; Rajeshwer N Srivastava; Nar Singh Verma
Journal:  Int J Crit Illn Inj Sci       Date:  2012-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.